Open original FDA record ↗Recall record
- FDA identifier
- Z-0616-2011
- Company in FDA record
- Fresenius Kabi, LLC
- FDA classification date
- Dec 16, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Potential for patient hematocrit dropped to levels lower than expected post-treatment.
Source facts
- Action
- On October 21, 2010, Fresenius Kabi, LLC in Redmond, WA sent a "Field Safety Corrective Action" Letter dated October 18, 2010 to their US Consignees/Customers. On October 22, 2010, the firm followed up with their customers by telephone call. The letter informed the consignees/customers that the Red Blood Cell (RBC) exchange sets for use on the AS104 Blood Cell Separation Device are being recalled. The consignees/customers were advised to examine their stock and determine if they have any affected products on hand. They were instructed to discontinue distributing, using, dispensing the affected products, and return the product to Fresenius Kabi, LLC, 8635 154th Avenue, NE, Redmond, WA 98052. The consignees/customers were also instructed to notify their sub-account customers if the products were further distributed and to complete the Product Recall Response Form and fax it back to 425-242-2101. T If you have any further questions concerning the recall, please contact the Quality Assurance Manager at 800-909-3872.
- Initiated
- 2010-10-18
- Root cause
- Device Design
- Terminated
- 2011-10-05
- Distribution
- Nationwide distribution: including states of: AL, AR, AZ, CA, CT, GA, KY, MN, NC, NJ, OH, TN, and TX.
- Recall number
- Z-0616-2011
- Recall status
- Terminated
- CDRH record ID
- 95762
- FDA classified
- 2010-12-16
- Recall event number
- 57290